Evidence map›Paper›PMID 36684932›Full record

ArticleFrontiers in public health2022

Trends in prevalence, health disparities, and early detection of dementia: A 10-year nationally representative serial cross-sectional and cohort study.

Kevin Lu, Xiaomo Xiong, Minghui Li, Jing Yuan, Ye Luo, Daniela B Friedman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kevin LuDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia, SC, United States.
Xiaomo XiongDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia, SC, United States.
Minghui LiDepartment of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, TN, United States.
Jing YuanDepartment of Pharmacy Administration, Fudan University, Shanghai, China.
Ye LuoDepartment of Sociology, Anthropology and Criminal Justice, Clemson University, Clemson, SC, United States.
Daniela B FriedmanDepartment of Health Promotion, Education, and Behaviour, Arnold School of Public Health, University of South Carolina, Columbia, SC, United States.
University of South Carolina · USClemson University · USFudan University · CNUniversity of Tennessee Health Science Center · US

Funding

Carolina Center on Alzheimer's Disease and Minority Research (CCADMR)P30AG059294 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FRIEDMAN, DANIELA B., LEVKOFF, SUE E · 2018 to 2022
$3.2M
NIA NIH HHS P30 AG059294
6 · The paper itself

Abstract

Objective: To identify trends in the prevalence of mild cognitive impairment (MCI) and dementia, and to determine risk factors associated with the early detection of dementia among U.S. middle-aged and older adults. Methods: We used 10-year nationally representative longitudinal data from the Health and Retirement Study (HRS) (2006-2016). Adults aged 55 years or older were included to examine the trend. To identify the associated factors, adults aged 55 years or older in 2006 who developed MCI or dementia in subsequent waves until the 2016 wave were included. Early and late detection of dementia were identified using the Langa-Weir classification of cognitive function. Multivariate logistic regression models were used to identify factors associated with the early detection of dementia. Results: The sample size for the analysis of the prevalence of MCI and dementia ranged from 14,935 to 16,115 in the six survey years, and 3,729 individuals were identified to determine associated factors of the early detection of dementia. Among them, participants aged 65 years or older accounted for 77.9%, and male participants accounted for 37.2%. The 10-year prevalence of MCI and dementia was 14.5 and 6.6%, respectively. We also found decreasing prevalence trends in MCI (from 14.9 to 13.6%) and dementia (from 7.4 to 6.0%) overall in the past decade. Using logistic regression controlling for the year, non-Hispanic black (MCI: OR = 2.83, Conclusion: This study found a decreasing trend in the prevalence of MCI and dementia in the past decade and associated racial/ethnic and gender disparities among U.S. middle-aged and older adults. Healthcare policies and strategies may be needed to address health disparities in the prevalence and take the associated factors of the early detection of dementia into account in clinical settings.

Indexed as

Cognitive DysfunctionDementiaAgedCohort StudiesCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceAlzheimer's diseasedementiaearly detectionmiddle-aged and older populationsmild cognitive impairment

Identifiers

PMID36684932
PMCPMC9846104
OpenAlexW4313481932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.